Press Releases

Company News
View Summary Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results
Mar 2, 2015
PDF 26.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host 2014 Financial Results Conference Call on March 3, 2015
Feb 23, 2015
PDF 11.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals Initiates Clinical Study of Meth-Resistant Nexafed(R) Extended-Release Formulations
Feb 16, 2015
PDF 16.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Expands Meth-Resistant Decongestant Line With NEXAFED(R) Sinus Pressure + Pain
Feb 5, 2015
PDF 14.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Partners With Egalet Corporation to Commercialize Immediate Release Oxycodone Product Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Jan 8, 2015
PDF 14.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Acknowledges Distribution of Nexafed(R) by Kmart Pharmacy
Dec 23, 2014
PDF 12.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals Receives Additional U.S. Patent for Abuse Deterrent Drug Formulations
Dec 8, 2014
PDF 11.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Third Quarter 2014 Financial Results
Nov 3, 2014
PDF 26.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Third Quarter 2014 Financial Results Conference Call on November 4, 2014
Oct 28, 2014
PDF 11.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Update on Its Hydrocodone Bitartrate With Acetaminophen Tablets Development
Oct 16, 2014
PDF 15.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Hydrocodone Bitartrate With Acetaminophen Tablets Meet Clinical Endpoints
Sep 29, 2014
PDF 17.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Submits Formal Dispute Resolution Request With FDA Regarding Hydrocodone Bitartrate With Acetaminophen Tablets
Sep 15, 2014
PDF 15.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Receives Grant From National Institutes of Health to Fund Limitx(TM) Novel Abuse Deterrent Technology
Aug 27, 2014
PDF 15.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Update on FDA Discussions Surrounding Development of Aversion Hydrocodone With Acetaminophen Tablet
Aug 15, 2014
PDF 15.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Second Quarter 2014 Financial Results
Aug 4, 2014
PDF 22.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Second Quarter 2014 Financial Results Conference Call on August 5, 2014
Jul 24, 2014
PDF 11.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Update on Its Abuse Deterrent Hydrocodone/Acetaminophen Combination Drug
May 27, 2014
PDF 16.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Settlement of Patent Litigation With Sandoz Inc.
May 21, 2014
PDF 16.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
May 8, 2014
PDF 15.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces First Quarter 2014 Financial Results
May 5, 2014
PDF 20.3 KB Add to Briefcase
Showing 1-20 of 82 Page: 1 2 3 4 5  Next 20
Add to Briefcase = add release to Briefcase